| Those without hypertension (N = 3,056) | Those with hypertension (N = 1,024) | p-value |
---|---|---|---|
Insulin resistance index | Â | Â | Â |
 TyG index | 8.30 ± 0.55 | 8.56 ± 0.61 | < 0.001 |
 TG/HDL-C | 2.31 ± 2.67 | 3.22 ± 3.89 | < 0.001 |
 METS-IR | 2.00 ± 0.21 | 2.10 ± 0.23 | < 0.001 |
 ZJU index | 125.42 ± 16.08 | 131.67 ± 17.46 | < 0.001 |
Stage I hypertension | Â | Â | Â |
 Isolated systolic hypertension, % | 0 | 364 (35.5) |  |
 Isolated diastolic hypertension, % | 0 | 212 (20.7) |  |
 Combined hypertension, % | 0 | 163 (15.9) |  |
Stage II hypertension | 0 | 285 (27.8) | Â |
 Isolated systolic hypertension, % | 0 | 113 (11.0) |  |
 Isolated diastolic hypertension, % | 0 | 109 (10.6) |  |
 Combined hypertension, % | 0 | 63 (6.2) |  |
Age, years | 28.16 ± 5.81 | 30.28 ± 6.14 | < 0.001 |
Male sex, % | 2675 (87.5) | 994 (97.1) | < 0.001 |
Active alcohol intake, % | 1207 (39.5) | 479 (46.8) | < 0.001 |
Active tobacco smoking, % | 1069 (35.5) | 357 (34.9) | 0.90 |
Daily coffee intake ≥ 4 cups or 600 mL, % |  |  |  |
Moderate-intensity PA levels, % | Â | Â | Â |
 <150 min/wk | 697 (22.8) | 198 (19.3) | 0.03 |
 150–299 min/wk | 1165 (38.1) | 389 (38.0) |  |
 ≥300 min/wk | 1194 (39.1) | 437 (42.7) |  |
SBP, mmHg | 111.96 ± 10.33 | 132.71 ± 9.26 | < 0.001 |
DBP, mmHg | 66.41 ± 7.19 | 80.79 ± 10.02 | < 0.001 |
Waist circumference, cm | 81.20 ± 8.30 | 85.88 ± 7.94 | < 0.001 |
Body mass index, kg/m2 | 24.17 ± 3.07 | 26.00 ± 2.99 | < 0.001 |
Blood tests | Â | Â | Â |
 Total cholesterol, mg/dL | 171.56 ± 32.85 | 180.06 ± 35.17 | < 0.001 |
 LDL-C, mg/dL | 103.12 ± 29.10 | 109.42 ± 30.19 | < 0.001 |
 HDL-C, mg/dL | 49.19 ± 10.28 | 47.51 ± 10.17 | < 0.001 |
 TG, mg/dL | 102.56 ± 81.60 | 137.39 ± 128.01 | < 0.001 |
 FPG, mg/dL | 92.66 ± 12.68 | 94.62 ± 13.94 | < 0.001 |
 SUA, mg/dL | 6.40 ± 1.37 | 6.91 ± 1.42 | < 0.001 |
 BUN, mg/dL | 12.62 ± 2.85 | 12.87 ± 2.93 | 0.02 |
 eGFR, mL/min/1.73m2 | 101.40 ± 14.93 | 98.66 ± 14.73 | < 0.001 |